CANCER STATISTICS

S.L. Parker, T. Tong, S. Bolden, P.A. Wingo, "Cancer Statistics, 1997," CA-A Cancer Journal for Clinicians , 47:5-27, 1997. (Cited in more than 545 papers since publication) Phyllis A. Wingo Comments by Phyllis A. Wingo, director of the Surveillance Research Program at the American Cancer Society in Atlanta Because cancer registries are not fully operational in every state, it's difficult to get a reliable calculation of the number of new cancer cases that occur in the United States each ye

Written byPhyllis Wingo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

S.L. Parker, T. Tong, S. Bolden, P.A. Wingo, "Cancer Statistics, 1997," CA-A Cancer Journal for Clinicians , 47:5-27, 1997. (Cited in more than 545 papers since publication)


Phyllis A. Wingo
Comments by Phyllis A. Wingo, director of the Surveillance Research Program at the American Cancer Society in Atlanta

Because cancer registries are not fully operational in every state, it's difficult to get a reliable calculation of the number of new cancer cases that occur in the United States each year. For more than 20 years the American Cancer Society (ACS) has been publishing annual reports in its journal CA-A Cancer Journal for Clinicians that include estimates of the number of new cancer cases and cancer deaths expected to occur in the upcoming year. As is typical of these reports, the 1997 version had a considerable impact.

"Scientists ... and the general public want to know an estimate or an approximation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies